Cargando…
Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study
BACKGROUND: Reports about the influence of the COVID-19 pandemic on the number of hospital admissions and in-hospital mortality during the first wave between March and May 2020 showed conflicting results and are limited by single-center or limited regional multicenter datasets. Aim of this analysis...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385100/ https://www.ncbi.nlm.nih.gov/pubmed/35978111 http://dx.doi.org/10.1007/s00392-022-02082-3 |
_version_ | 1784769525271494656 |
---|---|
author | Zeymer, Uwe Ahmadli, Vusal Schneider, Steffen Werdan, Karl Weber, Michael Hohenstein, Sven Hindricks, Gerhard Desch, Steffen Bollmann, Andreas Thiele, Holger |
author_facet | Zeymer, Uwe Ahmadli, Vusal Schneider, Steffen Werdan, Karl Weber, Michael Hohenstein, Sven Hindricks, Gerhard Desch, Steffen Bollmann, Andreas Thiele, Holger |
author_sort | Zeymer, Uwe |
collection | PubMed |
description | BACKGROUND: Reports about the influence of the COVID-19 pandemic on the number of hospital admissions and in-hospital mortality during the first wave between March and May 2020 showed conflicting results and are limited by single-center or limited regional multicenter datasets. Aim of this analysis covering all German federal states was the comprehensive description of hospital admissions and in-hospital mortality during the first wave of the COVID-19 pandemic. METHODS AND RESULTS: We conducted an observational study on hospital routine data (§21 KHEntgG) and included patients with the main diagnosis of acute myocardial infarction (ICD 21 and ICD 22). A total of 159 hospitals included 36,329 patients in the database, with 12,497 patients admitted with ST-elevation myocardial infarction (STEMI) and 23,832 admitted with non-ST-elevation myocardial infarction (NSTEMI). There was a significant reduction in the number of patients admitted with STEMI (3748 in 2020, 4263 in 2019 and 4486 in 2018; p < 0.01) and NSTEMI (6957 in 2020, 8437 in 2019 and 8438 in 2020; p < 0.01). These reductions were different between the Federal states of Germany. Percutaneous coronary intervention was performed more often in 2020 than in 2019 (odds ratio 1.13, 95% confidence interval [CI] 1.06–1.21) and 2018 (odds ratio 1.20, 95% CI 1.12–1.29) in NSTEMI and more often than in 2018 (odds ratio 1.26, 95% CI 1.10–1.43) in STEMI. The in-hospital mortality did not differ between the years for STEMI and NSTEMI, respectively. CONCLUSIONS: In this large representative sample size of hospitals in Germany, we observed significantly fewer admissions for NSTEMI and STEMI during the first COVID-19 wave, while quality of in-hospital care and in-hospital mortality were not affected. GRAPHICAL ABSTRACT: Admissions for STEMI and NSTEMI during the months March to May over 3 years and corresponding in-hospital mortality for patients with STEMI and NSTEMI in 159 German hospitals. (p-value for admissions 2020 versus 2019 and 2018: < 0.01; p-value for mortality: n.s.) [Image: see text] |
format | Online Article Text |
id | pubmed-9385100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-93851002022-08-18 Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study Zeymer, Uwe Ahmadli, Vusal Schneider, Steffen Werdan, Karl Weber, Michael Hohenstein, Sven Hindricks, Gerhard Desch, Steffen Bollmann, Andreas Thiele, Holger Clin Res Cardiol Original Paper BACKGROUND: Reports about the influence of the COVID-19 pandemic on the number of hospital admissions and in-hospital mortality during the first wave between March and May 2020 showed conflicting results and are limited by single-center or limited regional multicenter datasets. Aim of this analysis covering all German federal states was the comprehensive description of hospital admissions and in-hospital mortality during the first wave of the COVID-19 pandemic. METHODS AND RESULTS: We conducted an observational study on hospital routine data (§21 KHEntgG) and included patients with the main diagnosis of acute myocardial infarction (ICD 21 and ICD 22). A total of 159 hospitals included 36,329 patients in the database, with 12,497 patients admitted with ST-elevation myocardial infarction (STEMI) and 23,832 admitted with non-ST-elevation myocardial infarction (NSTEMI). There was a significant reduction in the number of patients admitted with STEMI (3748 in 2020, 4263 in 2019 and 4486 in 2018; p < 0.01) and NSTEMI (6957 in 2020, 8437 in 2019 and 8438 in 2020; p < 0.01). These reductions were different between the Federal states of Germany. Percutaneous coronary intervention was performed more often in 2020 than in 2019 (odds ratio 1.13, 95% confidence interval [CI] 1.06–1.21) and 2018 (odds ratio 1.20, 95% CI 1.12–1.29) in NSTEMI and more often than in 2018 (odds ratio 1.26, 95% CI 1.10–1.43) in STEMI. The in-hospital mortality did not differ between the years for STEMI and NSTEMI, respectively. CONCLUSIONS: In this large representative sample size of hospitals in Germany, we observed significantly fewer admissions for NSTEMI and STEMI during the first COVID-19 wave, while quality of in-hospital care and in-hospital mortality were not affected. GRAPHICAL ABSTRACT: Admissions for STEMI and NSTEMI during the months March to May over 3 years and corresponding in-hospital mortality for patients with STEMI and NSTEMI in 159 German hospitals. (p-value for admissions 2020 versus 2019 and 2018: < 0.01; p-value for mortality: n.s.) [Image: see text] Springer Berlin Heidelberg 2022-08-17 2023 /pmc/articles/PMC9385100/ /pubmed/35978111 http://dx.doi.org/10.1007/s00392-022-02082-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Zeymer, Uwe Ahmadli, Vusal Schneider, Steffen Werdan, Karl Weber, Michael Hohenstein, Sven Hindricks, Gerhard Desch, Steffen Bollmann, Andreas Thiele, Holger Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study |
title | Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study |
title_full | Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study |
title_fullStr | Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study |
title_full_unstemmed | Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study |
title_short | Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study |
title_sort | effects of the covid-19 pandemic on acute coronary syndromes in germany during the first wave: the covid-19 collateral damage study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385100/ https://www.ncbi.nlm.nih.gov/pubmed/35978111 http://dx.doi.org/10.1007/s00392-022-02082-3 |
work_keys_str_mv | AT zeymeruwe effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT ahmadlivusal effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT schneidersteffen effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT werdankarl effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT webermichael effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT hohensteinsven effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT hindricksgerhard effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT deschsteffen effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT bollmannandreas effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy AT thieleholger effectsofthecovid19pandemiconacutecoronarysyndromesingermanyduringthefirstwavethecovid19collateraldamagestudy |